Modulation of tumor immune microenvironment by TAS-115, a multi-receptor tyrosine kinase inhibitor, promotes antitumor immunity and contributes anti-PD-1 antibody therapy
Toshihiro Shibutani(Taiho Pharmaceutical (Japan)), Shuichi Ohkubo(Taiho Pharmaceutical (Japan))
Cited by 4
Related Papers
No related papers found
Powered by citation graph analysis